Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Hypoglycemia Evaluation and Management

Definition and Recognition

  • The American Diabetes Association defines hypoglycemia as blood glucose <70 mg/dL, with severity classified in three levels: Level 1 (<70 mg/dL but ≥54 mg/dL), Level 2 (<54 mg/dL), and Level 3 (severe event requiring assistance) 1, 3
  • Review of hypoglycemia history is recommended at every clinical encounter for all individuals at risk 1
  • Screening for impaired hypoglycemia awareness is recommended at least annually using validated tools like Clarke score, Gold score, or Pedersen-Bjergaard score 1, 3

Immediate Treatment Protocol

  • For conscious patients with hypoglycemia, the American Diabetes Association recommends administering 15-20g of glucose orally and rechecking blood glucose after 15 minutes 1
  • If hypoglycemia persists, treatment with another 15-20g of glucose is recommended 2
  • Once blood glucose is trending up, providing a meal or snack to prevent recurrence is advised 3

Comprehensive Evaluation

  • Assessment of risk factors for hypoglycemia, including medication use, history of severe hypoglycemia, and renal insufficiency, is recommended 1, 4
  • Screening for fear of hypoglycemia in high-risk individuals is recommended at least annually 1
  • Evaluation of cognitive function regularly, with increased vigilance for hypoglycemia if impairment is found, is advised 1

Prevention Strategies

  • Consideration of continuous glucose monitoring (CGM) for individuals at high risk for hypoglycemia is recommended 1
  • Prescription of glucagon for all individuals taking insulin or at high risk for hypoglycemia is advised 1
  • Provision of structured education on hypoglycemia prevention and treatment is recommended 1
  • For patients with hypoglycemia unawareness or recent severe hypoglycemia, raising glycemic targets to strictly avoid hypoglycemia and considering deintensifying or switching diabetes medications is recommended 1, 3
  • Implementation of a standardized hospital-wide hypoglycemia treatment protocol in hospitalized patients is advised 4, 6, 7

Special Considerations

  • For patients with type 1 diabetes, never holding basal insulin even when taking nothing by mouth is recommended 4
  • For patients transitioning from intravenous to subcutaneous insulin, administration of basal insulin 2 hours before discontinuing IV infusion is advised 4, 5